Version July 2025
| Vaccine | United States | China | Ukraine | Colombia | India | The Republic of Korea (South Korea) |
| Bacille Calmette-Guérin | – | Birth | 3 days | Birth | Birth | Birth to 1 month |
| Diphtheria, tetanus, pertussis | DTaP 2 months 4 months 6 months 15 to 18 months 4 to 6 years
Tdap 11 years | DTaP 3 months 4 months 5 months
DT 6 years | DTwP 2 months 4 months 6 months 18 months
DT 6 years
Td 16 years and every 10 years thereafter until age 66 years | DTwP 2 months 4 months 6 months 18 months 5 years
Tdap >7 years | DTwP 6 weeks 10 weeks 14 weeks 16 to 24 months 5 to 6 years
Td 10 years 16 years | DTaP 2 months 4 months 6 months 15 to 18 months 4 to 6 years
Td 11 to 12 years
Tdap 11 to 12 years |
| Haemophilus influenzae type b | 2 months 4 months 6 months 12 to 15 months | – | 2 months 4 months 12 months | 2 months 4 months 6 months | 6 weeks 10 weeks 14 weeks | 2 months 4 months 6 months 12 to 15 months |
| Hepatitis A | 12 to 23 months (second dose 6 months after first) | 18 months 2 years | – | 1 year | – | 12 to 23 months (second dose 6 to 18 months after first) |
| Hepatitis B | Birth 1 to 2 months 6 to 18 months | Birth 1 month 6 months | 1 day 2 months 6 months | Birth 2 months 4 months 6 months | Birth 6 weeks 10 weeks 14 weeks | Birth 1 month 6 months |
| Human papillomavirus | 2- or 3-dose series beginning at 11 years | – | – | 2-dose series for females beginning at age 9 years | – | 12 years (second dose 6 months after first) |
| Influenza | Annually for those ≥6 months | Annually for those ≥6 months and children with chronic conditions | Annually for children age 6 month through 17 years | Annually for children age 6 through 23 months and children with chronic conditions | – | Annually for those 6 months through 12 years and children ≥6 months with chronic conditions |
| Japanese encephalitis (JE) | – | Live, attenuated 8 months 2 years
Inactivated 8 months 7 to 10 days after first dose 2 years 6 years | – | – | Live, attenuated 9 to 12 months 16 to 24 months
Inactivated 9 to 12 months 16 to 24 months (JE vaccine is not given throughout India) | Live, attenuated 12 to 23 months (second dose 12 months after the first)
Inactivated 12 to 23 months 7 to 30 days after first dose 12 months after second dose 6 years 12 years |
| Measles, mumps, rubella | MMR 12 to 15 months 4 to 6 years | MR 8 months
MMR 18 months | MMR 12 months 6 years | MMR 1 year 5 years | Measles 9 to 12 months 16 to 24 months
MR 9 to 12 months 16 to 24 months | MMR 12 to 15 months 4 to 6 years |
| Meningococcal | MCV4 11 to 12 years 16 to 18 years | MenA 6 months 9 months
MenAC 3 years 6 years | – | MCV4 2 months 4 months 6 months | – | – |
| Pneumococcal conjugate vaccine (PCV) | 2 months 4 months 6 months 12 to 15 months | – | – | 2 months 4 months 12 months | 6 weeks 14 weeks 9 months (PCV is not given throughout India) | 2 months 4 months 6 months 12 to 15 months |
| Poliovirus | IPV 2 months 4 months 6 to 18 months 4 to 6 years | IPV 2 months 3 months
OPV 3 months 4 months 4 years | OPV 6 months 18 months 6 years 14 years | IPV 2 months 4 months 6 months
OPV 6 months 18 months 4 years | IPV 6 weeks 14 weeks
OPV Birth 6 weeks 10 weeks 14 weeks 16 to 24 months | IPV 2 months 4 months 6 to 18 months 4 to 6 years |
| Rotavirus | 2 months 4 months 6 months (depending on vaccine) | – | – | 2 months 4 months | 6 weeks 10 weeks 14 weeks | – |
| Varicella | 12 to 15 months 4 to 6 years | – | – | 1 year | – | 12 to 15 months |
